Other studies over the last few years have suggested that serum levels of interleukins and TNF-α may be used to identify patients who are prone to develop local or systemic complications and were compared with CRP which has been employed in the prediction of severity of acute pancreatitis. The gene discussed is CRP; the disease is acute pancreatitis.